FDA Approves Expanded Indication for Telix’s Illuccix to Include Patient Selection for PSMA-Directed Radioligand Therapy

Indianapolis, IN (United States) | 16 March 2023 — Telix Pharmaceuticals today announces that the United States Food and Drug Administration (FDA) has approved a supplementary New Drug Application (sNDA) for Illuccix® (kit for the preparation of gallium Ga 68 gozetotide injection) to enable its use for the selection of patients with metastatic prostate cancer, for whom 177Lu 177 PSMA-directed […]

Read more

FDA Approves Orserdu

FDA Approves Orserdu (elacestrant) for Patients with ESR1 Mutations in ER+, HER2- Advanced or Metastatic Breast Cancer ESR1 mutations are present in up to 40% of ER+, HER2- advanced or metastatic breast cancers. ESR1 mutations are a known driver of resistance to standard endocrine therapy, and so far, have been difficult to treat. Orserdu is the first endocrine innovation in […]

Read more

As US Bumps Against Debt Ceiling, Medicare Becomes a Bargaining Chip

The Host While repealing the Affordable Care Act seems to have fallen off congressional Republicans’ to-do list for 2023, plans to cut Medicare and Medicaid are back. The GOP wants Democrats to agree to cut spending on both programs in exchange for a vote to prevent the government from defaulting on its debts. Meanwhile, the nation’s health care workers — […]

Read more

How Optimism Can Close the Medicaid Coverage Gap

More than 2 million low-income people — half of them in Florida and Texas — are uninsured because they are stuck in a coverage gap: They earn too much to qualify for Medicaid, but because of a quirk of the Affordable Care Act, they earn too little to qualify for a subsidized ACA marketplace plan. The problem affects people in […]

Read more

They Lost Medicaid When Paperwork Was Sent to an Empty Field, Signaling the Mess to Come

BELFAST, Tenn. — Three years ago, Mason Lester, a rambunctious toddler, tumbled off his family’s porch and broke his wrist. His mother, nine months pregnant, rushed him to a nearby hospital, where she made a confounding discovery: Their health insurance had vanished. Alarmed, Katie Lester called the Tennessee Medicaid agency, TennCare, which had covered her during a prior pregnancy and […]

Read more

Who Doesn’t Text in 2022? Most State Medicaid Programs

West Virginia will use the U.S. Postal Service and an online account this summer to connect with Medicaid enrollees about the expected end of the covid public health emergency, which will put many recipients at risk of losing their coverage. What West Virginia won’t do is use a form of communication that’s ubiquitous worldwide: text messaging. “West Virginia isn’t set […]

Read more

ACA Sign-Ups for Low-Income People Roll Out Amid Brokers’ Concerns About Losing Their Cut

Insurance agent Cindy Holtzman was a little surprised by the notice from Bright HealthCare, one of the insurers that offer Affordable Care Act coverage in her area. The company’s February note said its health plan sign-ups saw “extraordinary growth” — passing the “one-million-member mark” in the previous year — and tied that success to the good relationships it has with […]

Read more

What Do We Really Know About Vaccine Effectiveness?

The politicization of covid vaccines — and, well, just about everything else having to do with the pandemic — has led to confusion, if not utter fatigue. And some posts circulating on social media — this slickly edited piece on YouTube, for example — seem to build on these feelings, attempting to cast doubt on the effectiveness of the vaccines. […]

Read more

3 States Limit Nursing Home Profits in Bid to Improve Care

Nursing homes receive billions of taxpayers’ dollars every year to care for chronically ill frail elders, but until now, there was no guarantee that’s how the money would be spent. Massachusetts, New Jersey and New York are taking unprecedented steps to ensure they get what they pay for, after the devastating impact of covid-19 exposed problems with staffing and infection […]

Read more

KHN’s ‘What the Health?’: Much Ado About Drug Prices

Can’t see the audio player? Click here to listen on SoundCloud. You can also listen on Spotify, Apple Podcasts, Stitcher, Pocket Casts or wherever you listen to podcasts. Congressional Democrats are finding it harder to actually write legislation to lower drug prices than it is to make promises about it. But the drug price provisions of the $3.5 trillion social-spending bill are critical — not only […]

Read more
1 2 3 24